Baker Bros. Advisors »

Sensei Biotherapeutics shares owned by Baker Bros. Advisors

Quarter-by-quarter ownership of Sensei Biotherapeutics (FTH) shares owned by Baker Bros. Advisors from 13F filings

Historical chart of Baker Bros. Advisors investment in Sensei Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sensei Biotherapeutics held by Baker Bros. Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sensei Biotherapeutics by Baker Bros. Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $32M 1.3M 25.00

More positions owned by Baker Bros. Advisors

Incyte Corporation (INCY)
BeOne Medicines Sponsored Ads (ONC)
Revolution Medicines (RVMD)
Madrigal Pharmaceuticals (MDGL)
ACADIA Pharmaceuticals (ACAD)
Kymera Therapeutics (KYMR)
Insmed Incorporated Com Par $.01 (INSM)
Celcuity (CELC)
Kodiak Sciences (KOD)
Rhythm Pharmaceuticals (RYTM)
Praxis Precision Medicines I (PRAX)
Alkermes SHS (ALKS)
Summit Therapeutics (SMMT)
Grail (GRAL)
Abcellera Biologics (ABCL)

View all positions for Baker Bros. Advisors

Top funds holding Sensei Biotherapeutics

Suvretta Capital Management
venBio Select Advisor
Baker Bros. Advisors
Balyasny Asset Management
Cormorant Asset Management
RA Capital Management
Vivo Capital
Fairmount Funds Management
Logos Global Management
Caligan Partners
Trails Edge Capital Partners
Franklin Resources
Octagon Capital Advisors
ADAR1 Capital Management
Marshall Wace

View all funds holding Sensei Biotherapeutics